Cargando…
Analysis of 13-valent pneumococcal polysaccharide conjugate vaccine among children born in Hangzhou from 2017 to 2021
BACKGROUND: 13-valent pneumococcal polysaccharide conjugate vaccine (PCV13) has been introduced in Hangzhou since 2017, whereas its current immunization state in children is not clear. Therefore, this study aims to describe the PCV13 vaccination distribution among children born in Hangzhou from 2017...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10267870/ https://www.ncbi.nlm.nih.gov/pubmed/37325318 http://dx.doi.org/10.3389/fpubh.2023.1184059 |
_version_ | 1785059016644231168 |
---|---|
author | Che, Xinren Chen, Qinghua Liu, Yan Gu, Lintao Lu, Zhaojun Gu, Wenwen Wang, Jun Jiang, Wei Du, Jian Zhang, Xiaoping Xu, Yuyang Zhang, Xuechao Wang, Jing Xie, Qixin Yang, Yingying |
author_facet | Che, Xinren Chen, Qinghua Liu, Yan Gu, Lintao Lu, Zhaojun Gu, Wenwen Wang, Jun Jiang, Wei Du, Jian Zhang, Xiaoping Xu, Yuyang Zhang, Xuechao Wang, Jing Xie, Qixin Yang, Yingying |
author_sort | Che, Xinren |
collection | PubMed |
description | BACKGROUND: 13-valent pneumococcal polysaccharide conjugate vaccine (PCV13) has been introduced in Hangzhou since 2017, whereas its current immunization state in children is not clear. Therefore, this study aims to describe the PCV13 vaccination distribution among children born in Hangzhou from 2017 to 2021 to provide data for reducing vaccination differences among different populations. METHODS: Descriptive epidemiology was used for data analysis and PCV13 vaccination related information of children was collected from children vaccination management system of Zhejiang Province (ZJCVMS). RESULTS: Among the 649,949 children born in Hangzhou from 2017 to 2021, 169,230 were vaccinated with an average full course vaccination rate of 26.0%. The full course vaccination rates in 5 years were different (P = 0.000) with an increasing trend (P (fortrend) < 0.01). The first dose vaccination rates were different in 5 years (P = 0.000) with an increasing trend (P (fortrend) < 0.01). The distribution of age when first dose PCV13 was administered varied, most people at 2 months and least people at 5 months. The full course vaccination rate varied by areas, highest in central urban areas and lowest in remote areas respectively (all P-value < 0.05). Overall, the full course vaccination rate of PCV13 was higher in the registered residence population than the non-registered residence population, which was 136,693 (31.4%) and 32,537 (15.1%) respectively (P = 0.000). The full course vaccination rates were the same between men and women (P = 0.502), which was 87,844 for men (26.0%) and 81,386 for women (26.1%). CONCLUSION: Although the number of people who received PCV13 full course vaccination and received the first dose vaccination showed yearly increasing trends in Hangzhou, the full course vaccination rate for the whole population was relatively low. In addition, the PCV13 vaccination rates also differed by geography and household registration status. Measures such as expanding vaccination publicity or including national immunization should be taken to increase vaccination rates and reduce the differences in vaccination among groups with different characteristics. |
format | Online Article Text |
id | pubmed-10267870 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-102678702023-06-15 Analysis of 13-valent pneumococcal polysaccharide conjugate vaccine among children born in Hangzhou from 2017 to 2021 Che, Xinren Chen, Qinghua Liu, Yan Gu, Lintao Lu, Zhaojun Gu, Wenwen Wang, Jun Jiang, Wei Du, Jian Zhang, Xiaoping Xu, Yuyang Zhang, Xuechao Wang, Jing Xie, Qixin Yang, Yingying Front Public Health Public Health BACKGROUND: 13-valent pneumococcal polysaccharide conjugate vaccine (PCV13) has been introduced in Hangzhou since 2017, whereas its current immunization state in children is not clear. Therefore, this study aims to describe the PCV13 vaccination distribution among children born in Hangzhou from 2017 to 2021 to provide data for reducing vaccination differences among different populations. METHODS: Descriptive epidemiology was used for data analysis and PCV13 vaccination related information of children was collected from children vaccination management system of Zhejiang Province (ZJCVMS). RESULTS: Among the 649,949 children born in Hangzhou from 2017 to 2021, 169,230 were vaccinated with an average full course vaccination rate of 26.0%. The full course vaccination rates in 5 years were different (P = 0.000) with an increasing trend (P (fortrend) < 0.01). The first dose vaccination rates were different in 5 years (P = 0.000) with an increasing trend (P (fortrend) < 0.01). The distribution of age when first dose PCV13 was administered varied, most people at 2 months and least people at 5 months. The full course vaccination rate varied by areas, highest in central urban areas and lowest in remote areas respectively (all P-value < 0.05). Overall, the full course vaccination rate of PCV13 was higher in the registered residence population than the non-registered residence population, which was 136,693 (31.4%) and 32,537 (15.1%) respectively (P = 0.000). The full course vaccination rates were the same between men and women (P = 0.502), which was 87,844 for men (26.0%) and 81,386 for women (26.1%). CONCLUSION: Although the number of people who received PCV13 full course vaccination and received the first dose vaccination showed yearly increasing trends in Hangzhou, the full course vaccination rate for the whole population was relatively low. In addition, the PCV13 vaccination rates also differed by geography and household registration status. Measures such as expanding vaccination publicity or including national immunization should be taken to increase vaccination rates and reduce the differences in vaccination among groups with different characteristics. Frontiers Media S.A. 2023-05-30 /pmc/articles/PMC10267870/ /pubmed/37325318 http://dx.doi.org/10.3389/fpubh.2023.1184059 Text en Copyright © 2023 Che, Chen, Liu, Gu, Lu, Gu, Wang, Jiang, Du, Zhang, Xu, Zhang, Wang, Xie and Yang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Public Health Che, Xinren Chen, Qinghua Liu, Yan Gu, Lintao Lu, Zhaojun Gu, Wenwen Wang, Jun Jiang, Wei Du, Jian Zhang, Xiaoping Xu, Yuyang Zhang, Xuechao Wang, Jing Xie, Qixin Yang, Yingying Analysis of 13-valent pneumococcal polysaccharide conjugate vaccine among children born in Hangzhou from 2017 to 2021 |
title | Analysis of 13-valent pneumococcal polysaccharide conjugate vaccine among children born in Hangzhou from 2017 to 2021 |
title_full | Analysis of 13-valent pneumococcal polysaccharide conjugate vaccine among children born in Hangzhou from 2017 to 2021 |
title_fullStr | Analysis of 13-valent pneumococcal polysaccharide conjugate vaccine among children born in Hangzhou from 2017 to 2021 |
title_full_unstemmed | Analysis of 13-valent pneumococcal polysaccharide conjugate vaccine among children born in Hangzhou from 2017 to 2021 |
title_short | Analysis of 13-valent pneumococcal polysaccharide conjugate vaccine among children born in Hangzhou from 2017 to 2021 |
title_sort | analysis of 13-valent pneumococcal polysaccharide conjugate vaccine among children born in hangzhou from 2017 to 2021 |
topic | Public Health |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10267870/ https://www.ncbi.nlm.nih.gov/pubmed/37325318 http://dx.doi.org/10.3389/fpubh.2023.1184059 |
work_keys_str_mv | AT chexinren analysisof13valentpneumococcalpolysaccharideconjugatevaccineamongchildrenborninhangzhoufrom2017to2021 AT chenqinghua analysisof13valentpneumococcalpolysaccharideconjugatevaccineamongchildrenborninhangzhoufrom2017to2021 AT liuyan analysisof13valentpneumococcalpolysaccharideconjugatevaccineamongchildrenborninhangzhoufrom2017to2021 AT gulintao analysisof13valentpneumococcalpolysaccharideconjugatevaccineamongchildrenborninhangzhoufrom2017to2021 AT luzhaojun analysisof13valentpneumococcalpolysaccharideconjugatevaccineamongchildrenborninhangzhoufrom2017to2021 AT guwenwen analysisof13valentpneumococcalpolysaccharideconjugatevaccineamongchildrenborninhangzhoufrom2017to2021 AT wangjun analysisof13valentpneumococcalpolysaccharideconjugatevaccineamongchildrenborninhangzhoufrom2017to2021 AT jiangwei analysisof13valentpneumococcalpolysaccharideconjugatevaccineamongchildrenborninhangzhoufrom2017to2021 AT dujian analysisof13valentpneumococcalpolysaccharideconjugatevaccineamongchildrenborninhangzhoufrom2017to2021 AT zhangxiaoping analysisof13valentpneumococcalpolysaccharideconjugatevaccineamongchildrenborninhangzhoufrom2017to2021 AT xuyuyang analysisof13valentpneumococcalpolysaccharideconjugatevaccineamongchildrenborninhangzhoufrom2017to2021 AT zhangxuechao analysisof13valentpneumococcalpolysaccharideconjugatevaccineamongchildrenborninhangzhoufrom2017to2021 AT wangjing analysisof13valentpneumococcalpolysaccharideconjugatevaccineamongchildrenborninhangzhoufrom2017to2021 AT xieqixin analysisof13valentpneumococcalpolysaccharideconjugatevaccineamongchildrenborninhangzhoufrom2017to2021 AT yangyingying analysisof13valentpneumococcalpolysaccharideconjugatevaccineamongchildrenborninhangzhoufrom2017to2021 |